Induction Healthcare Group PLC (INHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Induction Healthcare Group PLC (INHC) has a cash flow conversion efficiency ratio of -0.052x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-938.00K ≈ $-114.13 USD) by net assets (GBX18.19 Million ≈ $2.21K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Induction Healthcare Group PLC net asset quality index to measure how much of total assets are equity-financed.
Induction Healthcare Group PLC - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Induction Healthcare Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Induction Healthcare Group PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Induction Healthcare Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Induction Healthcare Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Advanced Info Service Public Company Limited
F:AISF
|
0.311x |
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
-0.525x |
|
Stora Enso Oyj ser. R
ST:STE-R
|
0.015x |
|
Goldstone Resources Ltd
LSE:GRL
|
-0.201x |
|
Viaplay Group AB Series A
ST:VPLAY-A
|
0.037x |
|
Greiffenberger AG
F:GRF
|
0.089x |
|
Arc Minerals Limited
LSE:ARCM
|
0.000x |
|
Titon Holdings Plc
LSE:TON
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Induction Healthcare Group PLC (2019–2024)
The table below shows the annual cash flow conversion efficiency of Induction Healthcare Group PLC from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Induction Healthcare Group PLC stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | GBX20.38 Million ≈ $2.48K |
GBX-1.09 Million ≈ $-132.26 |
-0.053x | +53.85% |
| 2023-03-31 | GBX24.30 Million ≈ $2.96K |
GBX-2.81 Million ≈ $-341.65 |
-0.116x | -137.00% |
| 2022-03-31 | GBX42.26 Million ≈ $5.14K |
GBX-2.06 Million ≈ $-250.76 |
-0.049x | +79.99% |
| 2021-03-31 | GBX16.47 Million ≈ $2.00K |
GBX-4.01 Million ≈ $-488.14 |
-0.244x | +9.36% |
| 2020-03-31 | GBX12.45 Million ≈ $1.51K |
GBX-3.35 Million ≈ $-407.11 |
-0.269x | -132.84% |
| 2019-03-31 | GBX-2.64 Million ≈ $-321.45 |
GBX-2.16 Million ≈ $-263.17 |
0.819x | -- |
About Induction Healthcare Group PLC
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom. The company offers Zesty, a patient engagement platform that provides smart appointment management, paperless letters, targeted questionnaires, and patient information; and Attend Anywhere for video consultations. It also offers registration, messaging, integration, and analytics and reporting plat… Read more